PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Clinical trials for PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM explained in plain language.
Never miss a new study
Get alerted when new PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM trials appear
Sign up with your email to follow new studies for PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise for hard-to-treat colorectal cancer in phase III trial
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (PD-1 monoclonal antibody) and bevacizumab to standard chemotherapy helps shrink tumors before surgery in people with a specific type of advanced colorectal cancer (pMMR/MSS). About 166 participants will be randomly assigned t…
Matched conditions: PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
New hope for Hard-to-Treat cancers: experimental drug enters human trials
Disease control Recruiting nowThis study tests an experimental drug called GV20-0251 in adults with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug can shrink or control the tumors. About 350 participants will take part in this early-phase trial.
Matched conditions: PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Phase: PHASE1, PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated May 20, 2026 12:08 UTC